WO2003023060A3 - Methode et trousse de diagnostic ou de surveillance du traitement du cancer du sein - Google Patents
Methode et trousse de diagnostic ou de surveillance du traitement du cancer du sein Download PDFInfo
- Publication number
- WO2003023060A3 WO2003023060A3 PCT/EP2002/009999 EP0209999W WO03023060A3 WO 2003023060 A3 WO2003023060 A3 WO 2003023060A3 EP 0209999 W EP0209999 W EP 0209999W WO 03023060 A3 WO03023060 A3 WO 03023060A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- diagnosing
- kit
- treatment
- controlling
- breast cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02774579A EP1409746A2 (fr) | 2001-09-06 | 2002-09-06 | Methode et trousse de diagnostic ou de surveillance du traitement du cancer du sein |
US10/488,828 US20050014208A1 (en) | 2001-09-06 | 2002-09-06 | Method and kit for diagnosing or controlling the treatment of breast cancer |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10143776A DE10143776A1 (de) | 2001-09-06 | 2001-09-06 | Verfahren und Kit zur Diagnostik oder Behandlungskontrolle von Brustkrebs |
DE10143776.5 | 2001-09-06 | ||
PCT/EP2002/005489 WO2003023057A2 (fr) | 2001-09-06 | 2002-05-17 | Procede et kit de diagnostic destines a la selection et/ou detection qualitative et/ou quantitative de cellules |
EPPCT/EP02/05489 | 2002-05-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003023060A2 WO2003023060A2 (fr) | 2003-03-20 |
WO2003023060A3 true WO2003023060A3 (fr) | 2004-01-29 |
Family
ID=26010082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/009999 WO2003023060A2 (fr) | 2001-09-06 | 2002-09-06 | Methode et trousse de diagnostic ou de surveillance du traitement du cancer du sein |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1409746A2 (fr) |
WO (1) | WO2003023060A2 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE309393T1 (de) | 2001-09-06 | 2005-11-15 | Adnagen Ag | Verfahren zum qualitativen und/oder quantitativen nachweis von zellen |
WO2005059179A1 (fr) * | 2003-12-12 | 2005-06-30 | Bayer Pharmaceutical Corporation | Procede de prediction et de pronostic du cancer, et surveillance de traitement anticancereux |
WO2006017635A2 (fr) * | 2004-08-11 | 2006-02-16 | Albert Einstein College Of Medicine Of Yeshiva University | Isolation, expression genique et resistance chimiotherapeutique de cellules cancereuses motiles |
JP2006223194A (ja) * | 2005-02-17 | 2006-08-31 | Tosoh Corp | スタニオカルシン1(STC1)mRNAの測定方法 |
FR2892730A1 (fr) * | 2005-10-28 | 2007-05-04 | Biomerieux Sa | Methode pour detecter la presence ou le risque de developper un cancer |
EP1957672A2 (fr) * | 2005-10-28 | 2008-08-20 | Biomerieux Sa | Procede de detection du cancer |
FR2899239A1 (fr) * | 2006-03-31 | 2007-10-05 | Biomerieux Sa | Procede de detection du cancer |
EP2088204A1 (fr) * | 2008-02-05 | 2009-08-12 | Adnagen AG | Procédé et kit pour diagnostiquer ou contrôler le traitement du cancer ovarien |
GB201000688D0 (en) * | 2010-01-15 | 2010-03-03 | Diagenic Asa | Product and method |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994007139A1 (fr) * | 1992-09-14 | 1994-03-31 | Fodstad Oystein | Procede ameliore de detection de cellules cibles specifiques dans une population de cellules specialisees ou mixtes et solutions contenant une population de cellules mixtes |
DE19736691A1 (de) * | 1997-08-22 | 1999-02-25 | Michael Prof Dr Med Giesing | Verfahren zur Charakterisierung und Identifizierung disseminierter und metastasierter Krebszellen |
WO1999044064A1 (fr) * | 1998-02-27 | 1999-09-02 | Cli Oncology, Inc. | Methode et compositions de detection differentielle de cellules tumorales et de cellules metastatiques |
-
2002
- 2002-09-06 WO PCT/EP2002/009999 patent/WO2003023060A2/fr not_active Application Discontinuation
- 2002-09-06 EP EP02774579A patent/EP1409746A2/fr not_active Ceased
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994007139A1 (fr) * | 1992-09-14 | 1994-03-31 | Fodstad Oystein | Procede ameliore de detection de cellules cibles specifiques dans une population de cellules specialisees ou mixtes et solutions contenant une population de cellules mixtes |
DE19736691A1 (de) * | 1997-08-22 | 1999-02-25 | Michael Prof Dr Med Giesing | Verfahren zur Charakterisierung und Identifizierung disseminierter und metastasierter Krebszellen |
WO1999044064A1 (fr) * | 1998-02-27 | 1999-09-02 | Cli Oncology, Inc. | Methode et compositions de detection differentielle de cellules tumorales et de cellules metastatiques |
Non-Patent Citations (12)
Title |
---|
BALZAR M ET AL: "The biology of the 17-1A antigen (Ep-CAM)", JOURNAL OF MOLECULAR MEDICINE, SPRINGER VERLAG, DE, vol. 77, no. 10, October 1999 (1999-10-01), pages 699 - 712, XP000925817, ISSN: 0946-2716 * |
CHARPENTIER A H ET AL: "STC2 AND E2IG1, TWO NOVEL BREAST CANCER BIOMARKERS", PROCEEDINGS OF THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, NEW YORK, NY, US, vol. 42, no. 628, March 2001 (2001-03-01), pages 628, XP001119829, ISSN: 0197-016X * |
CHRYSOGELOS S A ET AL: "EGF RECEPTOR EXPRESSION, REGULATION, AND FUNCTION IN BREAST CANCER", BREAST CANCER RESEARCH AND TREATMENT, NIJHOFF, BOSTON, US, vol. 29, no. 1, 1994, pages 29 - 40, XP001118068, ISSN: 0167-6806 * |
COLTRERA MARC D ET AL: "Expression of Platelet-derived Growth Factor B-Chain and the Platelet-derived Growth Factor Receptor beta Subunit in Human Breast Tissue and Breast Carcinoma.", CANCER RESEARCH, vol. 55, no. 12, 1995, pages 2703 - 2708, XP001153992, ISSN: 0008-5472 * |
FUJIWARA Y ET AL: "ASSESSMENT OF STANNIOCALCIN-1 MRNA AS A MOLECULAR MARKER FOR MICROMETASTASES OF VARIOUS HUMAN CANCERS", INTERNATIONAL JOURNAL OF ONCOLOGY, EDITORIAL ACADEMY OF THE INTERNATIONAL JOURNAL OF ONCOLOGY,, GR, vol. 16, April 2000 (2000-04-01), pages 799 - 804, XP002938551, ISSN: 1019-6439 * |
GHOSSEIN R A ET AL: "Molecular detection of micrometastases and circulating tumor cells in solid tumors", CLINICAL CANCER RESEARCH, THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 5, no. 8, August 1999 (1999-08-01), pages 1950 - 1960, XP002225510, ISSN: 1078-0432 * |
HARDINGHAM J E ET AL: "IMMUNOBEAD-PCR: A TECHNIQUE FOR THE DETECTION OF CIRCULATING TUMOR CELLS USING IMMUNOMAGNETIC BEADS AND THE POLYMERASE CHAIN REACTION", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 53, 1 August 1993 (1993-08-01), pages 3455 - 3458, XP000605489, ISSN: 0008-5472 * |
MARTIN KATHERINE J ET AL: "High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 98, no. 5, 27 February 2001 (2001-02-27), pages 2646 - 2651, XP002188522, ISSN: 0027-8424 * |
NACHT MARIANA ET AL: "Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 59, no. 21, 1 November 1999 (1999-11-01), pages 5464 - 5470, XP002166291, ISSN: 0008-5472 * |
RACILA E ET AL: "Detection and charcterization of carcinoma cells in the blood", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 95, April 1998 (1998-04-01), pages 4589 - 4594, XP002132943, ISSN: 0027-8424 * |
SMITH B ET AL: "DETECTION OF MELANOMA CELLS IN PERIPHERAL BLOOD BY MEANS OF REVERSE TRANSCRIPTASE AND POLYMERASE CHAIN REACTION", LANCET THE, LANCET LIMITED. LONDON, GB, vol. 338, 16 November 1991 (1991-11-16), pages 1227 - 1229, XP002008751, ISSN: 0140-6736 * |
ZHONG X Y ET AL: "EVALUATING GA733-2 MRNA AS A MARKER FOR THE DETECTION OF MICROMETASTATIC BREAST CANCER IN PERIPHERAL BLOOD AND BONE MARROW", ARCHIVES OF GYNECOLOGY AND OBSTETRICS, SPRINGER VERLAG, BERLIN, DE, vol. 263, no. 1/2, 1999, pages 2 - 6, XP000929386, ISSN: 0932-0067 * |
Also Published As
Publication number | Publication date |
---|---|
WO2003023060A2 (fr) | 2003-03-20 |
EP1409746A2 (fr) | 2004-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03000527A (es) | Composiciones y metodos para la terapia y diagnostico de cancer ovarico. | |
AU2001272908A1 (en) | Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers | |
NZ512247A (en) | Compositions and methods for therapy and diagnosis of ovarian cancer | |
WO2002016413A8 (fr) | Vaccins | |
ATE486938T1 (de) | C-typ-lektin-transmembran-antigen, das in menschlichem prostatakrebs exprimiert wird, und verwendungen dieses antigens | |
WO2001040269A3 (fr) | Compositions et methodes destinees au traitement et au diagnostic du cancer du sein | |
ATE229073T1 (de) | Protein e25a, methoden zu dessen herstellung und anwendung | |
WO2005001092A3 (fr) | Compositions et procedes pour diagnostiquer et traiter le cancer | |
AU9021898A (en) | Prostate tumor polynucleotide and antigen compositions | |
WO2003023060A3 (fr) | Methode et trousse de diagnostic ou de surveillance du traitement du cancer du sein | |
NO174719C (no) | Fremgangsmåte for fremstilling av monoklonale antistoffer | |
WO2002078516A3 (fr) | Compositions et methodes de traitement et de diagnostic de cancers | |
WO2003023059A3 (fr) | Procede et necessaire destines au diagnostic ou au controle du traitement du cancer de l'intestin | |
ES2101695T3 (es) | Haptoglobina relacionada con el cancer (hpr). | |
WO2003013431A3 (fr) | Compositions et techniques de therapie et de diagnostic du cancer du sein | |
EP1696028A3 (fr) | Compositions et méthodes pour la thérapie et le diagnostic du cancer du sein | |
WO2000078960A3 (fr) | Compositions et methodes destinees au traitement et au diagnostic du cancer du sein | |
EP0839908A3 (fr) | ELF3, un membre de la famille ETS | |
ATE475710T1 (de) | Zusammensetzungen und verfahren für die therapie und diagnose von ovariumkrebs | |
WO2005042578A3 (fr) | Fragment d'anticorps fab specifique pour le cancer du sein | |
DE60139150D1 (de) | Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs | |
WO1999043812A3 (fr) | Gene dlc-1: gene putatif suppresseur de tumeurs | |
WO2001098339A3 (fr) | Compositions et procedes de traitement et de diagnostic du cancer du sein | |
EP1243653A3 (fr) | Protéine E25a, procédés de production et utilization | |
CY1108790T1 (el) | Συνθεσεις για τη θεραπεια και διαγνωση ωοθηκικου καρκινου |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FR GB GR IE IT LU MC NL PT SE SK TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002774579 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002774579 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10488828 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |